We use cookies to track usage and preferences.I Understand
An automated, parallel, solid-phase synthesis and screening strategy using commercially available aryl acetic acids as starting materials has discovered novel, non-peptide CCR1 antagonists (Ki < 100 nM).
Article metrics loading...
Full text loading...
Publication Date: 01 May 2002
Get immediate access to your online copy - available in PDF and ePub formats